These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3755554)

  • 1. Ibuprofen bio-availability. A comparison of Brufen and Inza.
    Müller FO; Hundt HK; Van Dyk M; Groenewoud G; Luus HG
    S Afr Med J; 1986 Aug; 70(4):197-9. PubMed ID: 3755554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of three commercial preparations of ibuprofen 600 mg.
    Källström E; Heikinheimo M; Quiding H
    J Int Med Res; 1988; 16(1):44-9. PubMed ID: 3350204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of two new oral formulations of ibuprofen.
    Benvenuti C; Cancellieri V; Gambaro V; Lodi F; Marozzi E; Scaroni C
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):308-12. PubMed ID: 3733280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability of two tablet formulations of ibuprofen.
    el-Sayed YM; Gouda MW; al-Khamis KI; al-Meshal MA; al-Dhawailie AA; al-Rayes S; Bin-Salih SA; al-Rashood KA
    Int J Clin Pharmacol Ther; 1995 May; 33(5):294-8. PubMed ID: 7655769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sucralfate on ibuprofen absorption in normal volunteers.
    Pugh MC; Small RE; Garnett WR; Townsend RJ; Willis HE
    Clin Pharm; 1984; 3(6):630-3. PubMed ID: 6548940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
    Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
    S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose absorption profiles and bioavailability of two different salbutamol tablets.
    Jonkman JH; Freie HM; van der Boon WJ; Grasmeijer G
    Arzneimittelforschung; 1986 Jul; 36(7):1133-5. PubMed ID: 3768084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the absorption from three ibuprofen formulations.
    Regazzi BM; Rondanelli R; Ciaroelli L; Bartoli AL; Rampini A
    Int J Clin Pharmacol Res; 1986; 6(6):469-73. PubMed ID: 3804520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and platelet aggregation inhibitory activity of solufenum. A comparison with ibuprofen.
    Latini R; Villa S; Gerna M; Tognoni G; de Gaetano G
    Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):492-5. PubMed ID: 924705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen.
    Ceppi Monti N; Gazzaniga A; Gianesello V; Stroppolo F; Lodola E
    Arzneimittelforschung; 1992 Apr; 42(4):556-9. PubMed ID: 1642682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of commercially available ibuprofen oral dosage forms in humans.
    Gillespie WR; DiSanto AR; Monovich RE; Albert KS
    J Pharm Sci; 1982 Sep; 71(9):1034-8. PubMed ID: 7131270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers.
    Saano V; Paronen P; Peura P; Vidgren M
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):381-5. PubMed ID: 1748537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
    Pargal A; Kelkar MG; Nayak PJ
    Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen.
    Giagoudakis G; Markantonis SL
    Pharmacotherapy; 2005 Jan; 25(1):18-25. PubMed ID: 15767216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study to compare ibuprofen effervescent granules with ibuprofen tablets in the treatment of acute dental pain.
    Sharma NK; Kindelan JD; Hutchinson D; Lancaster L
    Prim Dent Care; 1994 Sep; 1(1):5-8. PubMed ID: 8941780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ibuprofen in man IV: absorption and disposition.
    Wagner JG; Albert KS; Szpunar GJ; Lockwood GF
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):381-99. PubMed ID: 6527231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common cold and influenza symptom management: the use of pharmacokinetic considerations to predict the efficacy of a twice-daily treatment for colds and flu.
    Stillings M; Little S; Sykes J
    Curr Med Res Opin; 2003; 19(8):791-9. PubMed ID: 14687451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose bioavailability of two different digoxin tablets.
    Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
    Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tablets.
    Cox SR; Brown MA; Squires DJ; Murrill EA; Lednicer D; Knuth DW
    Biopharm Drug Dispos; 1988; 9(6):539-49. PubMed ID: 3228575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.